← All companies

KPRX

Kiora Pharmaceuticals, Inc.

KPRX Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.59

+0.04 +1.37%

Key statistics

from XBRL data in SEC filings

Market cap

$11.5M

Revenue (TTM)

$0.00

Net income (TTM)

-$236K

EPS (TTM)

$-2.70

P/E ratio

—

Dividend yield

—

Free cash flow

-$10.1M

Cash

$11.0M

Total assets

$21.2M

Gross margin

—

52-week range

$1.77 – $3.01

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jun 18, 2026 8-K Director or officer change; Shareholder vote results Jun 11, 2026 8-K Results of operations (earnings release) May 8, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 7, 2026 8-K Director or officer change; Regulation FD disclosure Apr 2, 2026 8-K Results of operations (earnings release) Mar 25, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Results of operations (earnings release) Nov 7, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Regulation FD disclosure Aug 13, 2025 8-K Results of operations (earnings release) Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Shareholder vote results Jun 4, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 3, 2025 8-K Results of operations (earnings release) May 9, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) Mar 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Director or officer change Jan 15, 2025 8-K Results of operations (earnings release) Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Regulation FD disclosure Oct 29, 2024 8-K Results of operations (earnings release) Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Other events Jul 30, 2024 8-K Director or officer change; Regulation FD disclosure; Other events Jul 1, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jun 7, 2024 8-K Results of operations (earnings release) May 10, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Amended charter or bylaws; Shareholder vote results May 3, 2024 8-K Results of operations (earnings release) Mar 25, 2024 10-K Fiscal year ended 2023-12-31 Mar 25, 2024 8-K Regulation FD disclosure Feb 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 1, 2024 8-K Entered a material agreement; Regulation FD disclosure Jan 31, 2024 8-K Delisting notice or listing-rule failure Jan 16, 2024 8-K Regulation FD disclosure Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023